It was reported by Shi et al. that predictive and prognostic values of CDK1 and MAD2L1 have been described in lung adenocarcinoma as higher expression of CDK1 is correlated to poor survival and higher chances of cancer recurrences [61]. This evidence concerns the gene CDK1 and lung adenocarcinoma.